A Prospective Study on 18F-DCFPyL PET / CT Imaging in Biochemical Recurrence of Prostate Cancer.

COMMERCIAL CLINICAL TRIAL

Home · TEC15-Nuclear and Molecular Medicine

Clinical trial information

Promoter: CURIUM PET FRANCE
Phase: III
Execution start: 18/09/2020
End of execution: 30/08/2021
IP: ANTONIO RODRIGUEZ FERNANDEZ